St. Jude Medical Company Profile (NYSE:STJ)

About St. Jude Medical

St. Jude Medical logoSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: STJ
  • CUSIP: 79084910
Key Metrics:
  • Previous Close: $79.63
  • 50 Day Moving Average: $79.12
  • 200 Day Moving Average: $76.48
  • 52-Week Range: $48.83 - $84.00
  • Trailing P/E Ratio: 34.62
  • Foreward P/E Ratio: 18.02
  • P/E Growth: 1.73
  • Market Cap: $22.69B
  • Outstanding Shares: 284,929,000
  • Beta: 1.16
  • Net Margins: 11.40%
  • Return on Equity: 27.60%
  • Return on Assets: 9.17%
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.71%
  • Quick Ratio: 1.18%
Additional Links:
Companies Related to St. Jude Medical:

Analyst Ratings

Consensus Ratings for St. Jude Medical (NYSE:STJ) (?)
Ratings Breakdown: 19 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.21)
Consensus Price Target: $74.71 (6.18% downside)

Analysts' Ratings History for St. Jude Medical (NYSE:STJ)
DateFirmActionRatingPrice TargetDetails
10/11/2016Cowen and CompanyReiterated RatingBuy$85.00View Rating Details
9/12/2016Jefferies GroupReiterated RatingHold$60.00View Rating Details
8/28/2016ArgusReiterated RatingHoldView Rating Details
8/28/2016Credit Suisse Group AGReiterated RatingNeutral$81.00View Rating Details
8/15/2016Barclays PLCReiterated RatingEqual Weight$83.00View Rating Details
7/20/2016Canaccord GenuitySet Price TargetHold$85.00View Rating Details
7/21/2016Leerink SwannReiterated RatingHold$85.00View Rating Details
7/17/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
7/15/2016WedbushDowngradeOutperform -> Neutral$70.00 -> $84.00View Rating Details
5/10/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$70.00 -> $80.00View Rating Details
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00View Rating Details
4/30/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
4/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
4/29/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
4/28/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
4/15/2016Bank of America Corp.Reiterated RatingBuy$66.00View Rating Details
3/28/2016Oppenheimer Holdings Inc.Boost Price TargetMarket Perform$57.00 -> $67.00View Rating Details
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00View Rating Details
3/16/2016NomuraInitiated CoverageBuy$64.00View Rating Details
1/25/2016Royal Bank Of CanadaLower Price TargetSector Perform$66.00 -> $57.00View Rating Details
1/15/2016Deutsche Bank AGLower Price TargetHold$65.00 -> $64.00View Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00View Rating Details
10/22/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
9/1/2015Evercore ISIReiterated RatingHold$80.00View Rating Details
8/28/2015S&P Equity ResearchReiterated RatingBuy$92.00View Rating Details
1/29/2015CRT CapitalLower Price TargetBuy$80.00 -> $78.00View Rating Details
(Data available from 10/20/2014 forward)


Earnings History for St. Jude Medical (NYSE:STJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$1.01$0.99$1.50 billion$1.50 billionViewListenView Earnings Details
7/20/2016Q216$1.06$1.06$1.55 billion$1.56 billionViewListenView Earnings Details
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details
4/22/2015Q115$0.91$0.93$1.35 billionViewN/AView Earnings Details
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details
10/17/2012$0.81$0.83ViewN/AView Earnings Details
7/18/2012$0.87$0.86ViewN/AView Earnings Details
4/18/2012$0.83$0.86ViewN/AView Earnings Details
1/25/2012$0.84$0.86ViewN/AView Earnings Details
10/19/2011$0.76$0.78ViewN/AView Earnings Details
7/20/2011$0.84$0.85ViewN/AView Earnings Details
4/20/2011$0.78$0.80ViewN/AView Earnings Details
1/26/2011$0.74$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for St. Jude Medical (NYSE:STJ)
Current Year EPS Consensus Estimate: $4.06 EPS
Next Year EPS Consensus Estimate: $4.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$1.04$0.92
Q2 20167$0.99$1.13$1.05
Q3 20166$0.98$1.03$1.01
Q4 20168$1.03$1.11$1.08
Q1 20177$0.99$1.16$1.03
Q2 20176$1.08$1.25$1.16
Q3 20175$1.09$1.16$1.12
Q4 20176$1.15$1.24$1.19
Q2 20181$1.30$1.30$1.30
(Data provided by Zacks Investment Research)


Current Dividend Information for St. Jude Medical (NYSE:STJ)
Annual Dividend:$1.24
Dividend Yield:1.56%
Dividend Growth:8.20% (3 Year Average)
Payout Ratio:53.91% (Based on Trailing 12 Months of Earnings)
30.54% (Based on Current Year Consensus EPS Estimate)
28.05% (Based on Next Year Consensus EPS Estimate)
Track Record:5 Years of Consecutive Dividend Growth

Dividend History for St. Jude Medical (NYSE:STJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for St. Jude Medical (NYSE:STJ)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 81.51%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for St. Jude Medical (NYSE:STJ)
DateHeadline logoAbbott, St. Jude Medical: Agreement Reached in Sale of Vascular Closure Products toTerumo (NYSE:STJ) - October 20 at 7:48 PM logoAbbott, St. Jude Medical to Sell Assets (ABT, STJ) - Investopedia (NYSE:STJ) - October 20 at 12:38 PM logoSt. Jude Medical, Inc. (NYSE:STJ) Files An 8-K - Market Exclusive (NYSE:STJ) - October 20 at 12:38 PM logoAbbott, St. Jude Divests $1B in Assets (ABT, STJ) (NYSE:STJ) - October 20 at 12:38 PM logoSt. Jude Medical Still a Buy Despite Product Concerns (NYSE:STJ) - October 20 at 12:38 PM logoSt. Jude Medical (STJ) Michael Rousseau on Q3 2016 Results - Earnings Call Transcript (NYSE:STJ) - October 19 at 7:07 PM logoSunTrust Banks Takes Over #206 Spot From St Jude Medical (NYSE:STJ) - October 19 at 7:07 PM
News IconTop Gainers of the Day: St. Jude Medical Inc. (NYSE:STJ) from Medical Appliances & Equipment (NYSE:STJ) - October 19 at 7:07 PM logoSt. Jude Medical’s Sales Rise 12% (NYSE:STJ) - October 19 at 7:07 PM logoSt. Jude Medical Reports Third Quarter 2016 Results (NYSE:STJ) - October 19 at 7:07 PM
News IconActive Runners Buzz: Weatherford International Plc (NYSE:WFT), St. Jude Medical, Inc. (NYSE:STJ) - NYSE Journal (press release) (NYSE:STJ) - October 19 at 11:27 AM
News IconSt. Jude Medical, Inc. (NYSE:STJ) Earnings on the Doorstep; Analysts Take Aim - CSZ News (NYSE:STJ) - October 19 at 11:27 AM logoEarnings Reaction History: St. Jude Medical, Inc., 44.4% Follow-Through Indicator, 2.3% Sensitive - Nasdaq (NYSE:STJ) - October 19 at 11:27 AM logoSt. Jude Faces New Safety Charges From Muddy Waters Capital (NYSE:STJ) - October 19 at 11:27 AM logoSt. Jude Medical's (STJ) Q3 Earnings Miss, Sales In-line (NYSE:STJ) - October 19 at 11:27 AM logoSt. Jude Medical (STJ) Stock Slips, Q3 Earnings Miss Estimates (NYSE:STJ) - October 19 at 11:27 AM logo[$$] St. Jude Medical's Sales Rise 12% (NYSE:STJ) - October 19 at 11:27 AM logoStocks Open Mixed; Intel Slides As GNC Muscles Up (NYSE:STJ) - October 19 at 11:27 AM logoSt. Jude Spars with Muddy Waters After Earnings Miss (NYSE:STJ) - October 19 at 11:27 AM logoSt Jude Medical Reaches Analyst Target Price (NYSE:STJ) - October 19 at 9:49 AM logoSt. Jude Medical Q3 Bottom Line Number Misses (NYSE:STJ) - October 19 at 8:49 AM logoSt. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation (NYSE:STJ) - October 18 at 7:21 PM logoSt. Jude, Abbott Sell Products to Terumo for $1.12 Billion (NYSE:STJ) - October 18 at 7:21 PM
News IconUpdate on St. Jude Medical Inc. (NYSE:STJ) for the day (NYSE:STJ) - October 18 at 7:21 PM logoAbbott, St. Jude Medical Plans to Sell $1.1 Billion in Assets After Deal Closes (NYSE:STJ) - October 18 at 7:21 PM logoSt. Jude Medical (STJ) Launches ADO II AS Trial to Study Congenital Heart Defects (NYSE:STJ) - October 18 at 7:21 PM
News IconSt. Jude Medical, FDA Announce New Clinical Trial to Treat Congenital Heart Defects (NYSE:STJ) - October 18 at 7:21 PM logoSt. Jude and Abbott to sell some medical devices for $1.12 billion (NYSE:STJ) - October 18 at 7:21 PM logoStocks Intraday Alert: St. Jude Medical Inc. (STJ), SolarCity Corporation (SCTY), UDR, Inc. (UDR) - iStreetWire (NYSE:STJ) - October 18 at 11:55 AM
News IconTrader's Round Up: Invacare Corporation (NYSE:IVC), St. Jude Medical, Inc. (NYSE:STJ), PETVIVO HLDGS INC COM ... - The Independent Republic (NYSE:STJ) - October 18 at 11:55 AM logoSt. Jude Medical (STJ) Launches ADO II AS Trial to Study Congenital Heart Defects - (NYSE:STJ) - October 18 at 11:55 AM logoSt. Jude Medical, FDA and Top Pediatric Cardiology Experts Announce New Clinical Trial to Treat Congenital Heart ... - Business Wire (press release) (NYSE:STJ) - October 18 at 11:55 AM logoSt. Jude Medical, FDA and Top Pediatric Cardiology Experts Announce New Clinical Trial to Treat Congenital Heart Defects (NYSE:STJ) - October 18 at 11:55 AM logoAbbott and St. Jude to sell products to Terumo (NYSE:STJ) - October 18 at 11:55 AM logoETF’s with exposure to St. Jude Medical, Inc. : October 18, 2016 (NYSE:STJ) - October 18 at 11:55 AM logoBRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp (NYSE:STJ) - October 18 at 9:21 AM logoSt. Jude forms cyber panel after claims of heart-device bugs (NYSE:STJ) - October 17 at 7:20 PM logo1:01 pm St. Jude Medical says forming cyber security medical advisory board (NYSE:STJ) - October 17 at 7:20 PM logoSt. Jude Medical Announces it is Forming a Cyber Security Medical Advisory Board (NYSE:STJ) - October 17 at 7:20 PM logoWhat to Look For When St. Jude Medical (STJ) Reports Q3 Earnings (NYSE:STJ) - October 17 at 7:20 PM logoUPDATE 1-St Jude forms cyber panel after claims of heart-device bugs (NYSE:STJ) - October 17 at 5:38 PM logoSt Jude forms cyber panel after claims of heart-device bugs (NYSE:STJ) - October 17 at 2:54 PM
News IconLeading stocks in today’s market: St. Jude Medical Inc. (NYSE:STJ) (NYSE:STJ) - October 17 at 11:15 AM logoSt. Jude Medical (STJ) Q3 Earnings: What's in the Cards? (NYSE:STJ) - October 17 at 11:15 AM
News IconSteady Stocks Movements: St. Jude Medical, Inc. (NYSE:STJ ... - The Independent Republic (NYSE:STJ) - October 16 at 11:37 AM
News IconA look at a High Market Cap Stock: St. Jude Medical Inc., STJ – The ... - The Daily Leicester (NYSE:STJ) - October 16 at 11:37 AM
News IconSt. Jude Medical’s US launch, first implant of new deep brain stimulation system (NYSE:STJ) - October 14 at 7:19 PM
News IconSt. Jude Medical, Inc. Heart Device Recall (NYSE:STJ) - October 14 at 7:19 PM logoINVESTOR ALERT: Investigation of St. Jude Medical Inc. Announced by Law Offices of Howard G. Smith - Business Wire (press release) (NYSE:STJ) - October 14 at 10:47 AM logoINVESTOR ALERT: Investigation of St. Jude Medical Inc. Announced by Law Offices of Howard G. Smith (NYSE:STJ) - October 14 at 10:47 AM


St. Jude Medical (NYSE:STJ) Chart for Thursday, October, 20, 2016

Last Updated on 10/20/2016 by Staff